Sarepta Therapeutics, Inc. (SRPT) has 95 open-market insider trades by 24 insiders since 2012. The most active filer is Hans Lennart Rudolf Wigzell, Director.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Sandesh Mahatme | CFOVP | — | 8 | $53.8M | 2020-07-08 |
| David T. Howton | CLOVP | — | 8 | $43.3M | 2020-06-22 |
| Michael Andrew Chambers | Dir | — | 6 | $40.9M | 2026-06-04 |
| Richard Barry | Dir | — | 9 | $35.4M | 2026-06-04 |
| Douglas S. Ingram | CEOPres | — | 7 | $23.1M | 2025-12-07 |
| Hans Lennart Rudolf Wigzell | Dir | — | 10 | $16.2M | 2026-06-04 |
| Alexander Cumbo | CCOVP | — | 4 | $12.3M | 2020-02-28 |
| Edward M. Kaye M.D. | Dir | — | 5 | $4.8M | 2017-08-03 |
| M. Kathleen Behrens | Dir | — | 6 | $3.7M | 2026-06-04 |
| Ian Michael Estepan | COO | — | 3 | $2.4M | 2026-09-04 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Stephen Mayo | Director | Sell | $123K | 2026-03-12 |
| Ian Michael Estepan | COO | Sell | $588K | 2025-12-16 |
| Claude Nicaise | Director | Sell | $496K | 2025-03-12 |
| Hans Lennart Rudolf Wigzell | Director | Sell | $1.3M | 2024-12-12 |
| Kathryn Jean Boor | Director | Sell | $411K | 2024-12-05 |
| Ian Michael Estepan | CFO | Sell | $1.6M |
Companies that share insiders with SRPT, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| 2024-08-30 |
| Michael Andrew Chambers | Director | Buy | $9.9M | 2024-08-16 |
| Ryan Edward Brown | CLO & VP | Sell | $12.6M | 2024-06-25 |
| Bilal Arif | — | Sell | $3.6M | 2024-06-24 |
| Dallan Murray | — | Sell | $509K | 2024-05-02 |
| Kathryn Jean Boor | Director | Sell | $187K | 2024-03-11 |
| Hans Lennart Rudolf Wigzell | Director | Sell | $3.7M | 2024-03-08 |
| Stephen Mayo | Director | Sell | $771K | 2024-03-05 |
| Ryan Edward Brown | CLO & VP | Sell | $251K | 2024-03-01 |
| Bilal Arif | — | Sell | $515K | 2024-03-01 |